1-25800234-G-T

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_020451.3(SELENON):​c.4G>T​(p.Gly2Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000351 in 812,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00037 ( 0 hom. )

Consequence

SELENON
NM_020451.3 missense

Scores

2
3
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: -0.219

Publications

0 publications found
Variant links:
Genes affected
SELENON (HGNC:15999): (selenoprotein N) This gene encodes a glycoprotein that is localized in the endoplasmic reticulum. It plays an important role in cell protection against oxidative stress, and in the regulation of redox-related calcium homeostasis. Mutations in this gene are associated with early onset muscle disorders, referred to as SEPN1-related myopathy. SEPN1-related myopathy consists of 4 autosomal recessive disorders, originally thought to be separate entities: rigid spine muscular dystrophy (RSMD1), the classical form of multiminicore disease, desmin related myopathy with Mallory-body like inclusions, and congenital fiber-type disproportion (CFTD). This protein is a selenoprotein, containing the rare amino acid selenocysteine (Sec). Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. A second stop-codon redefinition element (SRE) adjacent to the UGA codon has been identified in this gene (PMID:15791204). SRE is a phylogenetically conserved stem-loop structure that stimulates readthrough at the UGA codon, and augments the Sec insertion efficiency by SECIS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2016]
SELENON Gene-Disease associations (from GenCC):
  • rigid spine muscular dystrophy 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics, G2P
  • SELENON-related myopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital myopathy 4A, autosomal dominant
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital fiber-type disproportion myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • desmin-related myopathy with Mallory body-like inclusions
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • rigid spine syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.406279).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SELENONNM_020451.3 linkc.4G>T p.Gly2Cys missense_variant Exon 1 of 13 ENST00000361547.7 NP_065184.2 Q9NZV5-1
SELENONNM_206926.2 linkc.4G>T p.Gly2Cys missense_variant Exon 1 of 12 NP_996809.1 Q9NZV5-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SELENONENST00000361547.7 linkc.4G>T p.Gly2Cys missense_variant Exon 1 of 13 1 NM_020451.3 ENSP00000355141.2 Q9NZV5-1
SELENONENST00000374315.1 linkc.4G>T p.Gly2Cys missense_variant Exon 1 of 12 5 ENSP00000363434.1 Q9NZV5-2
SELENONENST00000354177.9 linkc.4G>T p.Gly2Cys missense_variant Exon 1 of 12 5 ENSP00000346109.5 H9KV50
SELENONENST00000494537.2 linkn.4G>T non_coding_transcript_exon_variant Exon 1 of 13 3 ENSP00000508308.1 A0A804HLD6

Frequencies

GnomAD3 genomes
AF:
0.000247
AC:
36
AN:
145810
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000737
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000122
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000487
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000374
AC:
249
AN:
666226
Hom.:
0
Cov.:
8
AF XY:
0.000361
AC XY:
112
AN XY:
309946
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
12522
American (AMR)
AF:
0.00
AC:
0
AN:
778
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
4132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2856
South Asian (SAS)
AF:
0.00
AC:
0
AN:
13774
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
222
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1314
European-Non Finnish (NFE)
AF:
0.000401
AC:
244
AN:
608860
Other (OTH)
AF:
0.000230
AC:
5
AN:
21768
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000247
AC:
36
AN:
145810
Hom.:
0
Cov.:
30
AF XY:
0.000212
AC XY:
15
AN XY:
70896
show subpopulations
African (AFR)
AF:
0.0000737
AC:
3
AN:
40718
American (AMR)
AF:
0.00
AC:
0
AN:
14708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3384
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5094
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4784
European-Finnish (FIN)
AF:
0.000122
AC:
1
AN:
8228
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.000487
AC:
32
AN:
65660
Other (OTH)
AF:
0.00
AC:
0
AN:
2012
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000162
Hom.:
0
Bravo
AF:
0.000268

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Eichsfeld type congenital muscular dystrophy Uncertain:2
Sep 26, 2022
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 18, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 2 of the SELENON protein (p.Gly2Cys). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SELENON-related conditions. ClinVar contains an entry for this variant (Variation ID: 426515). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SELENON protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Uncertain:1
Apr 13, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.4G>T (p.G2C) alteration is located in exon 1 (coding exon 1) of the SEPN1 gene. This alteration results from a G to T substitution at nucleotide position 4, causing the glycine (G) at amino acid position 2 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Oct 01, 2020
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Eichsfeld type congenital muscular dystrophy;C0546264:Congenital myopathy with fiber type disproportion Uncertain:1
Oct 08, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.035
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
19
DANN
Benign
0.96
DEOGEN2
Benign
0.10
.;T;.
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.29
T;T;T
M_CAP
Pathogenic
0.87
D
MetaRNN
Benign
0.41
T;T;T
MetaSVM
Benign
-0.38
T
MutationAssessor
Benign
0.69
.;N;N
PhyloP100
-0.22
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-1.3
N;N;N
REVEL
Uncertain
0.30
Sift
Pathogenic
0.0
D;D;D
Sift4G
Benign
0.12
T;T;T
Polyphen
0.99, 1.0
.;D;D
Vest4
0.11
MutPred
0.30
Gain of catalytic residue at G2 (P = 0.0295);Gain of catalytic residue at G2 (P = 0.0295);Gain of catalytic residue at G2 (P = 0.0295);
MVP
0.89
MPC
0.25
ClinPred
0.42
T
GERP RS
2.0
PromoterAI
-0.0090
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.27
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs982364753; hg19: chr1-26126725; API